Disclaimer: Reimbursement services support and Novartis Pharmaceuticals Corporation cannot guarantee success in obtaining reimbursement, nor can they submit appeals on behalf of providers or patients.

Dedicated assistance from our team and educational resources to help support Novartis oncology patients as they start on treatment and throughout their treatment journey. Novartis Patient Support for ...

Unlike rival CDK 4/6 inhibitor abemaciclib, patients don't need to be lymph-node positive to receive ribociclib after surgery ...

According to Novartis, the Glivec International Patient Assistance Program has provided free treatment to nearly 27,000 patients in over 80 countries who would otherwise not have had not access to ...

Novartis' new data for Kesimpta showed reduced disability progression in relapsing multiple sclerosis patients. Continuous ...

Novartis’ Kisqali receives US FDA approval to reduce risk of recurrence in people with HR+/HER2- early breast cancer: Basel Thursday, September 19, 2024, 13:00 Hrs [IST] Novarti ...

Novartis says it intends to launch a variety of US patient access programmes to support ... insurance coverage and providing financial assistance for the uninsured or underinsured.

An FDA approval has officially lifted the curtain on a blockbuster market showdown between Novartis and Eli Lilly in early ...

Analyst Eric Le Berrigaud from Stifel Nicolaus maintained a Hold rating on Novartis AG (NOVN – Research Report) and keeping the price ...

Moreover, Genentech and Novartis have a co-payment program ... insurance may not have to pay anything per treatment after patient assistance kicks in. Co-payment assistance of up to $15,000 ...